INVST’s Immix Biopharma IMMX Stock Holding History

INVST’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,000	Closed	-$40.2K	–	257
2024 Q3	$40.2K	Hold	27,000	–	–	﹤0.01%	249
2024 Q2	$57.2K	Buy	+27,000	New	+$62K	0.01%	260

Other funds holding IMMX

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

INVST's IMMX Position: Q4 2024 in Review

INVST sold out of Immix Biopharma (IMMX) in Q4 2024, closing a stake of 27,000 shares — an estimated $40.2K sold.

INVST first reported a position in IMMX in Q2 2024 and held it in 2 quarters. The position peaked at $57.2K in Q2 2024. 23 funds tracked by Wall St. Rank hold IMMX as of Q4 2024.

INVST reported no remaining Immix Biopharma position as of Q4 2024 after selling out during the quarter.
INVST sold 27,000 Immix Biopharma shares in Q4 2024, an estimated $40.2K.
INVST first reported a position in Immix Biopharma in Q2 2024 and held it in 2 quarters.
INVST's Immix Biopharma position peaked at $57.2K in Q2 2024.
23 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2024.

Based on INVST's 13F filing for Q4 2024, filed 19 Feb 2025.